Profiling eicosanoids and phospholipids using LC-MS/MS: principles and recent applications
Related Experiment Video
Updated: May 21, 2026

Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
1ABF Analytisch-Biologisches Forschungslabor GmbH, Munich, Germany. josef.ecker@abf-lab.com
Abstract:
Eicosanoids are potent lipid mediators involved in numerous physiological and pathophysiological processes. Precursors are polyunsaturated fatty acids liberated from membrane phospholipids. Thus, profiling and quantification of these molecules has gained a lot of attention during last years. Eicosanoids and phospholipids are commonly profiled by LC-MS/MSbecause this technique allows accurate quantification within acceptable run-times. This article therefore focuses on liquid chromatography and the ESI-MS/MS analysis of proinflammatory lipid mediators, particularly arachidonic acid (C20:4) derived eicosanoids and their precursors phospholipids. Recent analytical developments for quantification of these compounds are highlighted and analytical challenges are discussed. Furthermore, applications such as the use of these molecules as biomarkers are presented.

